Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death by Na, R, Zheng, S.L, Han, M, Yu, H, Jiang, D, Shah, S, Ewing, C, Zhang, L, Novakovic, K, Petkewicz, J, Gulukota, K, Helseth, D, Quinn, M, Humphries, E, Wiley, K, Isaacs, S, Wu, Y, Liu, X, Zhang, N, Wang, C.-H, Khandekar, J, Hulick, P, Shevrin, D, Cooney, K, Shen, Z, Partin, A, Carter, H.B, Carducci, M, Eisenberger, M, Denmeade, S, McGuire, M, Walsh, P, Helfand, B, Brendler, C, Ding, Q, Xu, J, Isaacs, W

Get full text

481 - Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death by Na, R., Zheng, S.L., Han, M., Yu, H., Jiang, D., Shah, S., Ewing, C., Zhang, L., Novakovic, K., Petkewicz, J., Gulukota, K., Helseth, D., Quinn, M., Humphries, E., Wiley, K., Isaacs, S., Wu, Y., Liu, X., Zhang, N., Wang, C.-H., Khandekar, J., Hulick, P., Shevrin, D., Cooney, K., Shen, Z., Partin, A., Carter, H.B., Carducci, M., Eisenberger, M., Denmeade, S., McGuire, M., Walsh, P., Helfand, B., Brendler, C., Ding, Q., Xu, J., Isaacs, W.

Get full text

TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease by Vickman, Renee E., Aaron-Brooks, LaTayia, Zhang, Renyuan, Lanman, Nadia A., Lapin, Brittany, Gil, Victoria, Greenberg, Max, Sasaki, Takeshi, Cresswell, Gregory M., Broman, Meaghan M., Paez, J. Sebastian, Petkewicz, Jacqueline, Talaty, Pooja, Helfand, Brian T., Glaser, Alexander P., Wang, Chi-Hsiung, Franco, Omar E., Ratliff, Timothy L., Nastiuk, Kent L., Crawford, Susan E., Hayward, Simon W.

Get full text

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer by Carter, H. Ballentine, Helfand, Brian, Mamawala, Mufaddal, Wu, Yishuo, Landis, Patricia, Yu, Hongjie, Wiley, Kathleen, Na, Rong, Shi, Zhuqing, Petkewicz, Jacqueline, Shah, Sameep, Fantus, Richard J., Novakovic, Kristian, Brendler, Charles B., Zheng, S. Lilly, Isaacs, William B., Xu, Jianfeng

Get full text

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death by Na, Rong, Zheng, S. Lilly, Han, Misop, Yu, Hongjie, Jiang, Deke, Shah, Sameep, Ewing, Charles M, Zhang, Liti, Novakovic, Kristian, Petkewicz, Jacqueline, Gulukota, Kamalakar, Helseth Jr, Donald L, Quinn, Margo, Humphries, Elizabeth, Wiley, Kathleen E, Isaacs, Sarah D, Wu, Yishuo, Liu, Xu, Zhang, Ning, Wang, Chi-Hsiung, Khandekar, Janardan, Hulick, Peter J, Shevrin, Daniel H, Cooney, Kathleen A, Shen, Zhoujun, Partin, Alan W, Carter, H. Ballentine, Carducci, Michael A, Eisenberger, Mario A, Denmeade, Sam R, McGuire, Michael, Walsh, Patrick C, Helfand, Brian T, Brendler, Charles B, Ding, Qiang, Xu, Jianfeng, Isaacs, William B

Get full text

Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus by Kerr, Jessica L, Timpe, Erin M, Petkewicz, Katherine A

Get full text